A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation.

Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390 · see citing works

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

McKenna, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.03.002 · Cited by 321 · see citing works

Pharmacokinetics of Hoasca alkaloids in healthy humans

Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., Andrade, E. O., Andrade, E. O., & Mash, D. C. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00168-8 · Cited by 318 · see citing works

Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers

Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303 · see citing works

Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites

Pfleger, K., Maurer, H., & Weber, A. A. (1992) · Cited by 261 · see citing works

Hallucinogens and dissociative agents naturally growing in the United States

Halpern, J. H. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.03.003 · Cited by 219 · see citing works

Quantitation of N,N-dimethyltryptamine and Harmala alkaloids in human plasma after Oral dosing with Ayahuasca

Callaway, J. C., Raymon, L. P., Hearn, W. L., McKenna, D. J., Grob, C. S., Brito, G. S., & Mash, D. C. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.6.492 · Cited by 160 · see citing works

Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine

Ott, J. (1999) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1999.10471741 · Cited by 140 · see citing works

Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions

Callaway, J. C., & Grob, C. S. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399712 · Cited by 137 · see citing works

.beta.-Carbolines as benzodiazepine receptor ligands. 1. Synthesis and benzodiazepine receptor interaction of esters of .beta.-carboline-3-carboxylic acid

LIPPKE, K. P., Schunack, W. G., Wenning, W., & Mueller, W. E. (1983) · Journal of Medicinal Chemistry · doi:10.1021/jm00358a008 · Cited by 125 · see citing works

Monoamine Oxidase Inhibitor Poisoning Resulting from Internet Misinformation on Illicit Substances

Brush, D. E., Bird, S. B., & Boyer, E. W. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120030949 · Cited by 120 · see citing works

Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism

Schwarz, M. J., Houghton, P. J., Rose, S., Jenner, P. G., & Lees, A. J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00129-1 · Cited by 98 · see citing works

Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca

Yritia, M., Jordi Riba, A., Ortuño, J., Ramirez, A., Castillo, A., Alfaro, Y., de la Torre, R., & Barbanoj, M. J. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00397-5 · Cited by 85 · see citing works

A General Screening and Confirmation Approach to the Analysis of Designer Tryptamines and Phenethylamines in Blood and Urine Using GC-EI-MS and HPLC-Electrospray-MS

Vorce, S. P., & Sklerov, J. H. (2004) · Journal of Analytical Toxicology · doi:10.1093/jat/28.6.407 · Cited by 79 · see citing works

Foxy, a Designer Tryptamine Hallucinogen*

Meatherall, R. C., & Sharma, P. K. (2003) · Journal of Analytical Toxicology · doi:10.1093/jat/27.5.313 · Cited by 77 · see citing works

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F. D., Bastos, M. D. L., de Pinho, P. G., & Carvalho, M. C. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1513-x · Cited by 292 · see citing works

Designer drugs: mechanism of action and adverse effects

Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262 · see citing works

The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization

Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242 · see citing works

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.

Gable, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01652.x · Cited by 244 · see citing works

Recreational Use, Analysis and Toxicity of Tryptamines

Tittarelli, R., Mannocchi, G., Pantano, F., & Romolo, F. S. (2014) · Current Neuropharmacology · doi:10.2174/1570159x13666141210222409 · Cited by 220 · see citing works

The globalization of ayahuasca: harm reduction or benefit maximization?

Tupper, K. W. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.11.001 · Cited by 212 · see citing works

Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness

Hamill, J., Hallak, J. E. C., Dursun, S. M., & Baker, G. B. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180125095902 · Cited by 182 · see citing works

Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions

Shen, H.-W., Jiang, X.-L., C. Winter, J., & Yu, A.-M. (2010) · Current Drug Metabolism · doi:10.2174/138920010794233495 · Cited by 170 · see citing works

The epidemiology of 5-methoxy- <i>N, N</i> -dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118769063 · Cited by 140 · see citing works

Serotonin toxicity of serotonergic psychedelics

Malcolm, B., & Thomas, K. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05876-x · Cited by 138 · see citing works

Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment

Brierley, D. I., & Davidson, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.001 · Cited by 137 · see citing works

Analysis of toxic alkaloids in body samples

Beyer, J., Drummer, O. H., & Maurer, H. H. (2009) · Forensic Science International · doi:10.1016/j.forsciint.2008.12.006 · Cited by 118 · see citing works

A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract

Frison, G., Favretto, D., Zancanaro, F., Fazzin, G., & Ferrara, S. D. (2008) · Forensic Science International · doi:10.1016/j.forsciint.2008.05.003 · Cited by 118 · see citing works

Toxicokinetics and Toxicodynamics of Ayahuasca alkaloids N,N-dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: clinical and forensic impact

Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2020) · Pharmaceuticals · doi:10.3390/ph13110334 · Cited by 117 · see citing works

Rhabdomyolysis After Ingestion of “Foxy,” a Hallucinogenic Tryptamine Derivative

Alatrash, G., Majhail, N. S., & Pile, J. C. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.550 · Cited by 106 · see citing works

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat

Pic‐Taylor, A., da Motta, L. G., de Morais, J. A., Melo, W., Santos, A. D. F. A., Campos, L. A., Mortari, M. R., von Zuben, M. V., & Caldas, E. D. (2015) · Behavioural Processes · doi:10.1016/j.beproc.2015.05.004 · Cited by 102 · see citing works

Bioanalysis of New Designer Drugs

Wohlfarth, A., & Weinmann, W. (2010) · Bioanalysis · doi:10.4155/bio.10.32 · Cited by 89 · see citing works

Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology

SANTOS, R. G. D. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.763564 · Cited by 87 · see citing works

A narrative synthesis of research with 5-MeO-DMT

Ermakova, A. O., Dunbar, F., Rucker, J., & Johnson, M. W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211050543 · Cited by 90 · see citing works

A Review of the Potential Forensic Significance of Traditional Herbal Medicines

Byard, R. W. (2010) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2009.01252.x · Cited by 82 · see citing works

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment

Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works

Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study

van Oorsouw, K., Toennes, S. W., & Ramaekers, J. G. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06046-9 · Cited by 74 · see citing works

The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs

Riga, M. S., Sòria, G., Tudela, R., Artigas, F., & Celada, P. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000261 · Cited by 72 · see citing works

Drug–drug interactions involving classic psychedelics: A systematic review

Halman, A., Kong, G., Sarris, J. J., & Perkins, D. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231211219 · Cited by 74 · see citing works

Modern Instrumental Methods in Forensic Toxicology

Smith, M. L., Vorce, S. P., Holler, J. M., Shimomura, E. T., Magluilo, J., Jacobs, A. J., & Huestis, M. A. (2007) · Journal of Analytical Toxicology · doi:10.1093/jat/31.5.237 · Cited by 68 · see citing works

Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis

Mercolini, L., & Protti, M. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.06.046 · Cited by 68 · see citing works

Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis

Palma, Á., Ventura, M., Galindo, L., Fonseca, F., Grifell, M., Quintana, P., Fornís, I., Gil, C., Farré, M., & Torrens, M. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1320732 · Cited by 65 · see citing works

Determination of Designer Drug Cross-Reactivity on Five Commercial Immunoassay Screening Kits

Regester, L. E., Chmiel, J. D., Holler, J. M., Vorce, S. P., LEVINE, B. S., & Bosy, T. Z. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku133 · Cited by 60 · see citing works

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor

Halberstadt, A. L., Nichols, D. E., & Geyer, M. A. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2616-6 · Cited by 57 · see citing works

State of the art in bile analysis in forensic toxicology

Bévalot, F., Cartiser, N., Bottinelli, C., Guitton, J., & Fanton, L. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.10.034 · Cited by 58 · see citing works

Ayahuasca: Uses, Phytochemical and Biological Activities

Estrella-Parra, E. A., Almanza-Pérez, J. C., & Alarcón-Aguilar, F. J. (2019) · Natural Products and Bioprospecting · doi:10.1007/s13659-019-0210-5 · Cited by 56 · see citing works

An Update on the Implications of New Psychoactive Substances in Public Health

Simão, A. Y., Antunes, M., Cabral, E., Oliveira, P., Rosendo, L. M., Brinca, A. T., Alves, E., Marques, H., Rosado, T., Passarinha, L. A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084869 · Cited by 53 · see citing works

Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?

Lanaro, R., Calemi, D. B. D. A., Togni, L. R., Costa, J. L., Yonamine, M., Cazenave, S. O. S., & Linardi, A. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1013202 · Cited by 52 · see citing works

Identification of N,N‐dimethyltryptamine and β‐carbolines in psychotropic ayahuasca beverage

Gambelunghe, C., Aroni, K., Rossi, R., Moretti, L. D., & Bacci, M. (2008) · Biomedical Chromatography · doi:10.1002/bmc.1023 · Cited by 52 · see citing works

Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model

Wu, C., Jiang, X.-L., Shen, H.-W., & Yu, A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.011 · Cited by 50 · see citing works

Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015

Heise, C. W., & Brooks, D. E. (2016) · Journal of Medical Toxicology · doi:10.1007/s13181-016-0593-1 · Cited by 48 · see citing works

Toxicology and Analysis of Psychoactive Tryptamines

Malaca, S., Faro, A. F. L., Tamborra, A., Pichini, S., Busardò, F. P., & Huestis, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239279 · Cited by 47 · see citing works

Fatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE)

Gicquel, T., Richeval, C., Mesli, V., Gish, A., Hakim, F., Pelletier, R., Cornez, R., Balgairies, A., Allorge, D., & Gaulier, J. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110852 · Cited by 48 · see citing works

A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions

SANTOS, R. G. D. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.785846 · Cited by 47 · see citing works

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors

Halberstadt, A. L., Buell, M. R., Masten, V. L., Risbrough, V. B., & Geyer, M. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1247-z · Cited by 45 · see citing works

Biomedical analysis of New Psychoactive Substances (NPS) of natural origin

Faro, A. F. L., Trana, A. D., Maida, N. L., Tagliabracci, A., Giorgetti, R., & Busardò, F. P. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.112945 · Cited by 45 · see citing works

The pharmacological interaction of compounds in ayahuasca: a systematic review

Ruffell, S., Netzband, N., Bird, C., Young, A. H., & Juruena, M. F. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0884 · Cited by 45 · see citing works

New Psychoactive Substances: Health and Legal Challenges

Santos, I. C. S., Maia, D., Dinis‐Oliveira, R. J., & Barbosa, D. J. (2024) · Psychoactives · doi:10.3390/psychoactives3020018 · Cited by 41 · see citing works

Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics

Shen, H.-W., Wu, C., Jiang, X.-L., & Yu, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.020 · Cited by 40 · see citing works

Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish

Savoldi, R., Polari, D., Pinheiro‐da‐Silva, J., Silva, P. F., Soares, B. L., Yonamine, M., Freire, F. A. D. M., & Luchiari, A. C. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00139 · Cited by 40 · see citing works

Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells

Santillo, M. F., Liu, Y., Ferguson, M. S., Vohra, S., & Wiesenfeld, P. L. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.12.006 · Cited by 38 · see citing works

Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review

Simão, A. Y., Gonçalves, J., Duarte, A. P., Barroso, M., Cristóvão, A. C., & Gallardo, E. (2019) · Medicines · doi:10.3390/medicines6040106 · Cited by 40 · see citing works

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca

Berlowitz, I., Egger, K., & Cumming, P. D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.886408 · Cited by 40 · see citing works

Nutmegs and wild nutmegs: An update on ethnomedicines, phytochemicals, pharmacology, and toxicity of the Myristicaceae species

Barman, R., Bora, P. K., Saikia, J., Kemprai, P., Saikia, S. P., Haldar, S., & Banik, D. (2021) · Phytotherapy Research · doi:10.1002/ptr.7098 · Cited by 35 · see citing works

Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine

Halberstadt, A. L. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.01.005 · Cited by 35 · see citing works

Analytical techniques for the determination of tryptamines and β‐carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo‐shamanic urban practices

Gaujac, A., Navickiene, S., Collins, M. I., Brandt, S. D., & de Andrade, J. B. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1343 · Cited by 34 · see citing works

Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects

Lancelotta, R. L., & Davis, A. K. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1737763 · Cited by 33 · see citing works

Application of ambient ionization high resolution mass spectrometry to determination of the botanical provenance of the constituents of psychoactive drug mixtures

Lesiak, A. D., & Musah, R. A. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.06.009 · Cited by 33 · see citing works

Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice

Shen, H.-W., Jiang, X.-L., & Yu, A. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039107 · Cited by 29 · see citing works

Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status

Jiang, X.-L., Shen, H.-W., Mager, D. E., & Yu, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050724 · Cited by 29 · see citing works

Hallucinogenic plants of abuse

Cunningham, N. (2008) · Emergency Medicine Australasia · doi:10.1111/j.1742-6723.2008.01070.x · Cited by 29 · see citing works

Acute Intoxication following Dimethyltryptamine Ingestion

Bilhimer, M. H., Schult, R. F., Higgs, K. V., Wiegand, T. J., Gorodetsky, R. M., & Acquisto, N. M. (2018) · Case Reports in Emergency Medicine · doi:10.1155/2018/3452691 · Cited by 28 · see citing works

Ayahuasca Beverages: Phytochemical Analysis and Biological Properties

Gonçalves, J., Luís, Â., Gradillas, A., Garcı́a, A., Restolho, J., Fernández, N., Domingues, F., Gallardo, E., & Duarte, A. P. (2020) · Antibiotics · doi:10.3390/antibiotics9110731 · Cited by 29 · see citing works

Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors

Jiang, X.-L., Shen, H.-W., & Yu, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.013 · Cited by 26 · see citing works

Development of a LC–MS/MS Method to Analyze 5-Methoxy-N,N-Dimethyltryptamine and Bufotenine: Application to Pharmacokinetic Study

Shen, H.-W., Jiang, X.-L., & Yu, A. (2009) · Bioanalysis · doi:10.4155/bio.09.7 · Cited by 26 · see citing works

Ayahuasca and the traveller: A scoping review of risks and possible benefits

Houle, S. K. D., Evans, D., Carter, C. A., & Schlagenhauf, P. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102206 · Cited by 20 · see citing works

A Systematic Review on the Therapeutic Effects of Ayahuasca

Gonçalves, J., Luís, Â., Gallardo, E., & Duarte, A. P. (2023) · Plants · doi:10.3390/plants12132573 · Cited by 20 · see citing works

The State of the Art in Post-Mortem Redistribution and Stability of New Psychoactive Substances in Fatal Cases: A Review of the Literature

Menéndez-Quintanal, L. M., Matey, J. M., González, V. D. F., Serrano, B. B., Hernández-Díaz, F. J., Zapata, F., Montalvo, G., & García‐Ruiz, C. (2024) · Psychoactives · doi:10.3390/psychoactives3040033 · Cited by 21 · see citing works

Evaluation of the Cytotoxicity of Ayahuasca Beverages

Simão, A. Y., Gonçalves, J., Gradillas, A., Garcı́a, A., Restolho, J., Fernández, N., Rodilla, J. M., Barroso, M., Duarte, A. P., Cristóvão, A. C., et al. (2020) · Molecules · doi:10.3390/molecules25235594 · Cited by 19 · see citing works

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

Ragnhildstveit, A., Khan, R., Seli, P., Bass, L. C., August, R. J., Kaiyo, M., Barr, N., Jackson, L. K., Gaffrey, M. S., Barsuglia, J. P., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1271152 · Cited by 17 · see citing works

Tryptamines

Greene, S. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00015-8 · Cited by 17 · see citing works

Potential significance of medicinal plants in forensic analysis: A review

Alotaibi, S. S., Alshoaibi, D. S., Alamari, H. A., Albogami, S. M., Khan, E., AL-Shanbari, A. H., Darwish, H., Alshanqiti, B., Alghamdi, H., & Almalki, W. M. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.03.071 · Cited by 18 · see citing works

Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death

Wiltshire, P. E. J., Hawksworth, D. L., & Edwards, K. J. (2015) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2015.05.010 · Cited by 17 · see citing works

Effects of Hallucinogens on Neuronal Activity

Lladó-Pelfort, L., Celada, P., Riga, M. S., Troyano‐Rodriguez, E., Santana, N., & Artigas, F. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_473 · Cited by 17 · see citing works

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

Vorobyeva, N. S., & Kozlova, A. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927984 · Cited by 19 · see citing works

The adverse effects of hallucinogens from intramural perspective.

Frecska, E., & Luna, L. E. (2006) · PubMed · Cited by 16 · see citing works

Natural Product (Fungal and Herbal) Novel Psychoactive Substances

Gibbons, S., & Arunotayanun, W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00014-6 · Cited by 16 · see citing works

Alcaloides e o chá de ayahuasca: uma correlação dos "estados alterados da consciência" induzido por alucinógenos

de Souza, P. A. (2011) · Revista Brasileira de Plantas Medicinais · doi:10.1590/s1516-05722011000300015 · Cited by 15 · see citing works

Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy- N , N -dimethyltryptamine Analogs in Mice

Glatfelter, G. C., Clark, A. A., Cavalco, N. G., Landavazo, A., Partilla, J. S., Naeem, M., Golen, J. A., Chadeayne, A. R., Manke, D. R., Blough, B. E., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00513 · Cited by 14 · see citing works

Plasma vs heart tissue concentration in humans – literature data analysis of drugs distribution

Tylutki, Z., & Polak, S. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1944 · Cited by 14 · see citing works

Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry

de Morais, D. R., Lanaro, R., Barbosa, I. L., Santos, J. M., da Cunha, K. F., Hernandes, V. V., Tessaro, E. P., Gomes, C. S., Eberlin, M. N., & Costa, J. L. (2017) · Forensic Toxicology · doi:10.1007/s11419-017-0394-5 · Cited by 14 · see citing works

Ayahuasca: uma revisão dos aspectos farmacológicos e toxicológicos

Pires, A. P. S., de Oliveira, C. D. R., & Yonamine, M. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 14 · see citing works

Effects of hallucinogenic drugs on the human heart

Neumann, J., Dhein, S., Kirchhefer, U., Hofmann, B., & Gergs, U. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1334218 · Cited by 16 · see citing works

Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae)

Schwelm, H. M., Zimmermann, N., Scholl, T., Penner, J., Autret, A., Auwärter, V., & Neukamm, M. A. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab038 · Cited by 13 · see citing works

Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects

Nižňanský, Ľ., Nižnanská, Ž., Kuruc, R., Szórádová, A., Šikuta, J., & Zummerová, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041147 · Cited by 12 · see citing works

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms

Jiang, X.-L., Shen, H.-W., & Yu, A.-M. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.01.008 · Cited by 13 · see citing works

Syrian rue seeds interacted with acacia tree bark in an herbal stew resulted in N,N-dimethyltryptamine poisoning

Liu, C.-H., Chu, W.-L., Liao, S., Yang, C., & Lin, C.-C. (2019) · Clinical Toxicology · doi:10.1080/15563650.2019.1576877 · Cited by 10 · see citing works

Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans

Barman, R., Bora, P. K., Saikia, J., Konwar, P., Sarkar, A., Kemprai, P., Saikia, S. P., Haldar, S., Slater, R. J., & Banik, D. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113928 · Cited by 9 · see citing works

Fatal intoxications and inherited cardiac disorders in the young: where to draw the line?

Grassi, S., Vaiano, F., Dimitrova, A., Vullo, C., Croce, E. B., Rossi, R., Arena, V., Rossi, S. S., Campuzano, Ó., Brugada, R., et al. (2025) · International Journal of Legal Medicine · doi:10.1007/s00414-025-03439-9 · Cited by 9 · see citing works

Understanding ayahuasca effects in major depressive disorder treatment through in vitro metabolomics and bioinformatics

Zandonadi, F. D. S., Silva, A., Melo, A. A. S., Ignarro, R. S., Matos, T. S., dos Santos, E. A. F., Barbosa, L. D., de Oliveira, A. L. R., Porcari, A. M., & Sussulini, A. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04556-3 · Cited by 10 · see citing works

Synthetic Cannabinoids, Synthetic Cathinones, and Other Emerging Drugs of Abuse

Wilson, B., Tavakoli, H., DeCecchis, D., & Mahadev, V. (2013) · Psychiatric Annals · doi:10.3928/00485713-20131206-08 · Cited by 9 · see citing works

Toxicology of natural and synthetic aphrodisiacs

Hess, C., & Boehmer, A. (2020) · Rechtsmedizin · doi:10.1007/s00194-019-00368-x · Cited by 10 · see citing works

Optimizing real-world benefit and risk of new psychedelic medications: the need for innovative postmarket surveillance

Black, J. C., Monte, A. A., Dasgupta, N., Jewell, J. S., Rockhill, K. M., Olson, R. A., & Dart, R. C. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00233-1 · Cited by 7 · see citing works

Phalaris Toxicoses in Australian Livestock Production Systems: Prevalence, Aetiology and Toxicology

Alden, R., Hackney, B. F., Weston, L. A., & Quinn, J. C. (2014) · Journal of Toxins · doi:10.13188/2328-1723.1000003 · Cited by 7 · see citing works

Intoxicación por ayahuasca

Márquez, B. D. P., & Dietl, B. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.02.017 · Cited by 6 · see citing works

Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the “God Molecule”

Al-Imam, A., Motyka, M. A., Hoffmann, B., Magowska, A. M., & Michalak, M. (2023) · Pharmaceuticals · doi:10.3390/ph16060831 · Cited by 6 · see citing works

Ayahuasca et vulnérabilité chimique : à propos d’un cas

Hoizey, G., Chèze, M., Muckensturm, A., Eliot, E., Borlot, A.-L., Pépin, G., & Deveaux, M. (2017) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2017.02.001 · Cited by 5 · see citing works

Tryptamines

Greene, S. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818788-3.00014-0 · Cited by 5 · see citing works

Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine

Neumann, J., Dietrich, T., Azatsian, K., Hofmann, B., & Gergs, U. (2025) · Scientific Reports · doi:10.1038/s41598-025-91400-6 · Cited by 4 · see citing works

Analysis of N,N‐dimethyltryptamine ( DMT ) and its metabolites using LC – MS / MS for forensic purposes

Gomonit, M. M., Swortwood, M. J., Truver, M. T., & Skillman, B. N. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70013 · Cited by 4 · see citing works

Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice

Jiang, X.-L., Shen, H.-W., Mager, D. E., Schmidt, S., & Yu, A. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.007 · Cited by 4 · see citing works

A simple method for the determination of stimulant substances in postmortem blood: development, validation, and application in nearly 1000 forensic cases

Birk, L., dos Santos, B. P., Ossanes, D. S., Schwarz, P. D. S., Mesquita, M. L., Eller, S. C. W. D. S., & de Oliveira, T. F. (2025) · Forensic Toxicology · doi:10.1007/s11419-025-00725-4 · Cited by 3 · see citing works

Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data

Rached, G., Campana, A. M., Fiani, D., Nguyen, C. Y., den Eynde, V. V., Gillman, P. K., & Barnett, B. S. (2026) · CNS Drugs · doi:10.1007/s40263-025-01256-7 · Cited by 3 · see citing works

How to set up a psychedelic study: Unique considerations for research involving human participants

Glennon, M. J., Bird, C., Yadav, P., Kleine, P., Suseelan, S., Boman-Markaki, C., Kotoula, V., Butler, M., Leech, R., Roseman, L., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106657 · Cited by 5 · see citing works

Bufotenina como droga facilitadora de agresión sexual

Escayola, E. N., Vega, C. V., & Torrecilla, C. H. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.06.012 · Cited by 3 · see citing works

A fatal case of aspiration due to consumption of the hallucinogenic tryptamine derivative dipropyltryptamine (DPT)

Neukamm, M. A., Pollak, S., Thoma, V., Vogt, S., Huppertz, L. M., & Auwärter, V. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115959 · Cited by 6 · see citing works

To the Editor: The case report “A Fatal Intoxication Following the Ingestion of 5-Methoxy-N,N-Dimethyltryptamine in

(2015)

Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N-dimethyltryptamines

McIlhenny, E. H. (2012) · doi:10.31390/gradschool_dissertations.2049 · Cited by 1 · see citing works

Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca

Yritia, M., Jordi Riba, A., Ortuño, J., Ramirez, A., Castillo, A., Alfaro, Y., de la Torre, R., & Barbanoj, M. J. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00397-5 · Cited by 85 · see citing works

Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry

de Morais, D. R., Lanaro, R., Barbosa, I. L., Santos, J. M., da Cunha, K. F., Hernandes, V. V., Tessaro, E. P., Gomes, C. S., Eberlin, M. N., & Costa, J. L. (2017) · Forensic Toxicology · doi:10.1007/s11419-017-0394-5 · Cited by 14 · see citing works